WO2007079271A2 - Techniques for evaluating urinary stress incontinence - Google Patents
Techniques for evaluating urinary stress incontinence Download PDFInfo
- Publication number
- WO2007079271A2 WO2007079271A2 PCT/US2006/060032 US2006060032W WO2007079271A2 WO 2007079271 A2 WO2007079271 A2 WO 2007079271A2 US 2006060032 W US2006060032 W US 2006060032W WO 2007079271 A2 WO2007079271 A2 WO 2007079271A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pressure
- patient
- sensing catheter
- pressure sensing
- area under
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 206010066218 Stress Urinary Incontinence Diseases 0.000 title claims abstract description 30
- 206010011224 Cough Diseases 0.000 claims abstract description 58
- 210000002700 urine Anatomy 0.000 claims abstract description 6
- FEWJPZIEWOKRBE-JCYAYHJZSA-L L-tartrate(2-) Chemical group [O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O FEWJPZIEWOKRBE-JCYAYHJZSA-L 0.000 claims abstract description 3
- 239000003937 drug carrier Substances 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 230000002747 voluntary effect Effects 0.000 claims description 19
- 208000022170 stress incontinence Diseases 0.000 claims description 7
- 239000006199 nebulizer Substances 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims 4
- 238000005070 sampling Methods 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 1
- 238000012545 processing Methods 0.000 abstract description 11
- 238000001514 detection method Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 24
- 206010046543 Urinary incontinence Diseases 0.000 description 13
- 230000011514 reflex Effects 0.000 description 8
- 206010021639 Incontinence Diseases 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 210000003708 urethra Anatomy 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- 230000003202 urodynamic effect Effects 0.000 description 3
- 206010020853 Hypertonic bladder Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000010420 art technique Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 210000003903 pelvic floor Anatomy 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000003313 weakening effect Effects 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 208000037147 Hypercalcaemia Diseases 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 239000000464 adrenergic agent Substances 0.000 description 1
- 102000004305 alpha Adrenergic Receptors Human genes 0.000 description 1
- 108090000861 alpha Adrenergic Receptors Proteins 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 210000000133 brain stem Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000000188 diaphragm Anatomy 0.000 description 1
- DLNKOYKMWOXYQA-UHFFFAOYSA-N dl-pseudophenylpropanolamine Natural products CC(N)C(O)C1=CC=CC=C1 DLNKOYKMWOXYQA-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 102000015694 estrogen receptors Human genes 0.000 description 1
- 108010038795 estrogen receptors Proteins 0.000 description 1
- 210000002388 eustachian tube Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004704 glottis Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000000148 hypercalcaemia Effects 0.000 description 1
- 208000030915 hypercalcemia disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000036724 intravesical pressure Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 210000001989 nasopharynx Anatomy 0.000 description 1
- 210000000885 nephron Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004197 pelvis Anatomy 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- DLNKOYKMWOXYQA-APPZFPTMSA-N phenylpropanolamine Chemical compound C[C@@H](N)[C@H](O)C1=CC=CC=C1 DLNKOYKMWOXYQA-APPZFPTMSA-N 0.000 description 1
- 229960000395 phenylpropanolamine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000003998 progesterone receptors Human genes 0.000 description 1
- 108090000468 progesterone receptors Proteins 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/202—Assessing bladder functions, e.g. incontinence assessment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/202—Assessing bladder functions, e.g. incontinence assessment
- A61B5/205—Determining bladder or urethral pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6874—Bladder
Definitions
- This invention is directed to the field of medical devices and testing and, more particularly, to apparatus and techniques for evaluating urinary stress incontinence.
- urinary incontinence affects approximately twelve million persons in the United States alone. Although urinary incontinence can occur in both men and women, it is most common in women over the age of 50. There are many causes of UI, including age related atrophic changes in the genitourinary anatomy in women after menopause, enlargement of the prostate in men as well as generalized weakening of the pelvic floor muscles, medication side effects, immobility, infection of the urinary tract and various underlying medical comorbidities including diabetes and hypercalcemia.
- a patient experiencing urinary incontinence must be properly diagnosed to identify the specific type of incontinence from which the patient suffers.
- the treatments may be different, depending on the type of incontinence. Therefore, proper diagnosis becomes important at least for that reason.
- Stress incontinence may be responsive to treatment with exogenous estrogens, although this is not an effective treatment for all patients, particularly depending on age.
- Alternative treatments may include pelvic muscle exercises, ⁇ -adrenergic agents, such as phenylpropanolamine, that act on the ⁇ -adrenergic receptors along the urethra and increase urethral tone.
- treatment may include antispasmodic agents which tend to relax the wall of the bladder.
- a typical test employed to distinguish these two types of urinary incontinence is one which increases intra-abdominal pressure so as to, in turn, put pressure on the bladder.
- the Valsalva maneuver is one such test.
- the patient generates a muscular contraction of the chest, abdomen and diaphragm in a forced expiration against a closed glottis. This increases pressure within the thoracic cavity and also in the abdominal cavity.
- the Valsalva maneuver also refers to raising the pressure in the nasopharynx by a forced expiration with the mouth closed and the nostrils pinched, for example, to clear the patency of the Eustachian tubes.
- Other testing techniques involve having the patient jump up and down to jostle the bladder, or bend down so as to compress the abdomen.
- Yet another method involves having the patient generate one or more strong voluntary coughs.
- One of the problems associated with the prior art techniques is that some patient's are unable or are unwilling to perform the physical acts to the extent needed. For example, a patient may not be able to jump, or to bend, or to generate a strong voluntary cough. For some patient's they maybe able to perform these acts, but be unwilling to do so because an involuntary release of urine maybe embarrassing or contrary to what is considered proper in society.
- aspects of the invention are directed toward apparatus and techniques for evaluating urinary stress incontinence.
- the invention is directed toward evaluating urinary stress incontinence using a reflexive cough test (RCT), which triggers an involuntary cough on the part of the patient.
- RCT reflexive cough test
- Such an involuntary cough overcomes some of the problems of prior art techniques and produces a more reliable test for urinary stress incontinence.
- Figure 1 shows a flow chart of a technique for evaluating a patient for urinary stress incontinence in accordance with one aspect of the invention.
- FIG. 2 shows a flow chart of a technique for conducting a reflexive cough test (RCT).
- RCT reflexive cough test
- Figure 3 shows a catheter that can be used for carrying out various aspects of the invention.
- Figure 4 is an illustration of a hand held processing device that can be used to carry out the invention.
- Figure 5 is a block diagram of an exemplary processing device that can be used to carry out aspects of the invention.
- Figure 6 is a flow chart of software use to program a processing device in accordance with one aspect of the invention.
- Figure 7A and 7B illustrate test results comparing voluntary cough and involuntary cough techniques for assessing stress urinary incontinence.
- Figure 1 shows a flow chart of a technique for evaluating a patient for urinary stress incontinence in accordance with one aspect of the invention.
- pressure sensing catheter is inserted into a patient's empty bladder (100).
- the patient's bladder is then filled slowly with sterile water until 200ml have been delivered (110).
- the patient is then asked to voluntarily cough (120) and the results of the voluntary cough are recorded (130) by recording the variations in pressure as a function of time and by recording whether or not the cough induced involuntary expulsion of urine. See item 130.
- a reflex cough test is performed (140) and the results are recorded in a manner substantially similar to step 130. Details of the reflex cough tests are discussed more in conjunction with Figure 2.
- Figure 2 shows a flow chart of a technique for conducting a reflex cough test.
- the patient is administered a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier (200).
- the variations in bladder pressure that occur during the involuntary coughs induced by step 200 are then recorded and plotted for display (210).
- the patient is checked for any urinary leakage that occurs during the involuntary coughs (220).
- Figure 3 shows a catheter that can be used for carrying out various aspects of the invention.
- a catheter, 300 includes a pressure sensor 310 and conductive wires or paths which conduct the electrical output of the pressure sensor 310 to external circuitry.
- the wires or paths are hereinafter called pressure sensor leads 320.
- the catheter lumen can be utilized to fill or drain the patient's bladder as appropriate. Examples of a catheter usable in accordance with the invention may include a Foley catheter equipped with a pressure sensor.
- Figure 4 is an illustration of a hand held processing device that can be used to carry out the invention. As shown on the device display screen, the variation in pressure that occurs as a function of time during a voluntary or involuntary cough is displayed.
- Figure 5 is a block diagram of an exemplary processing device that can be utilized to carry out aspects of the invention.
- Figure 5 is a block diagram that illustrates a computer system 500 upon which an embodiment of the invention may be implemented.
- Computer system 500 includes a bus 502 or other communication mechanism for communicating information, and a processor 504 coupled with bus 502 for processing information.
- Computer system 500 also includes a main memory 506, such as a random access memory (RAM) or other dynamic storage device, coupled to bus 502 for storing information and instructions to be executed by processor 504.
- Main memory 506 also may be used for storing temporary variables or other intermediate information during execution of instructions to be executed by processor 504.
- Computer system 500 further includes a read only memory (ROM) 508 or other static storage device coupled to bus 502 for storing static information and instructions for processor 504.
- ROM read only memory
- a storage device 510 such as a magnetic disk or optical disk, is provided and coupled to bus 502 for storing information and instructions.
- Computer system 500 may be coupled via bus 502 to a display 512, such as a cathode ray tube (CRT), for displaying information to a computer user.
- a display 512 such as a cathode ray tube (CRT)
- An input device 514 is coupled to bus 502 for communicating information and command selections to processor 504.
- cursor control 516 is Another type of user input device
- cursor control 516 such as a mouse, a trackball, or cursor direction keys for communicating direction information and command selections to processor 104 and for controlling cursor movement on display 512.
- This input device typically has two degrees of freedom in two axes, a first axis (e.g., x) and a second axis (e.g., y), that allows the device to specify positions in a plane.
- Computer system 500 operates in response to processor 504 executing one or more sequences of one or more instructions contained in main memory 506. Such instructions may be read into main memory 506 from another computer-readable medium, such as storage device 510. Execution of the sequences of instructions contained in main memory 506 causes processor 504 to perform the process steps described herein. In alternative embodiments, hard- wired circuitry may be used in place of or in combination with software instructions to implement the invention. Thus, embodiments of the invention are not limited to any specific combination of hardware circuitry and software.
- Non- volatile media includes, for example, optical or magnetic disks, such as storage device 510.
- Volatile media includes dynamic memory, such as main memory 506.
- Transmission media includes coaxial cables, copper wire and fiber optics, including the wires that comprise bus 502. Transmission media can also take the form of acoustic or light waves, such as those generated during radio-wave and infra-red data communications.
- Computer-readable media include, for example, a floppy disk, a flexible disk, hard disk, magnetic tape, or any other magnetic medium, a CD-ROM, any other optical medium, punchcards, papertape, any other physical medium with patterns of holes, a RAM, a PROM, and EPROM, a FLASH-EPROM, any other memory chip or cartridge, a carrier wave as described hereinafter, or any other medium from which a computer can read.
- Various forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to processor 504 for execution.
- the instructions may initially be carried on a magnetic disk of a remote computer.
- the remote computer can load the instructions into its dynamic memory and send the instructions over a telephone line using a modem.
- a modem local to computer system 500 can receive the data on the telephone line and use an infra-red transmitter to convert the data to an infra-red signal.
- An infra-red detector can receive the data carried in the infra-red signal and appropriate circuitry can place the data on bus 502.
- Bus 502 carries the data to main memory 506, from which processor 504 retrieves and executes the instructions.
- the instructions received by main memory 506 may optionally be stored on storage device 510 either before or after execution by processor 504.
- FIG. 6 is a flow chart of software used to program a processing device in accordance with one aspect of the invention.
- the processing device is programmed to repetitively sample pressure output from the sensor (600).
- the processor can start recording data from the pressure sensor (610).
- the start signal can be generated by utilizing either a rapid increase in pressure, by detecting a pressure threshold being exceeded, or by receiving a trigger signal initiated by a user.
- Such a signal was discussed in conjunction with U.S. Patent Application Serial No. 10/783,442, filed February 20, 2004, entitled Apparatus For Evaluating A Patient's Laryngeal Cough Reflex And Associated Methods, by W. Robert Addington, Stuart Miller and Robert Stephens, referred to above.
- the processing unit After receipt of the starts signal, the processing unit stores the samples and displays the plot of the pressure sample values (620).
- AUC area under the curve of a plot of the sample values (630).
- the areas under the curve (AUC) values are calculated by the numerical integration of intravesical pressure over time with either Simpson's 3/8-rule or Bode (or Boole's) rule. Both Simpson's 3/8-rule and Bode (or Boole's) rule are methods of numerical integration that yield more accurate results for AUC than the trapezoidal method.
- the process may selectively display the calculated area under the curve to the user either with or separately from display of the plot of the sample values (640).
- Figure 7A and 7B illustrate test results comparing voluntary cough and involuntary cough techniques for assessing stress urinary incontinence. The testing that produced the results shown in Figure 7A and 7B are described as follows.
- Voluntary and involuntary (RCT) cough provocation maneuvers were performed during urodynamic testing in 6 women.
- the order of the cough provocation procedures was randomized.
- Cough Leak Point Pressure was assessed with a bladder volume of 200 mL. Leakage was determined by visual inspection of the perineum by the Investigator during the coughs, and electronically marked on the print-out. If the subject did not leak with either cough maneuver in the semi-recumbent position, the standing position was used. Urodynamic testing was completed with filling to capacity to observe for detrusor instability. After instruction, subjects performed a maximal forceful voluntary cough (VC) and an involuntary cough. The involuntary cough was elicited by stimulating the laryngeal cough reflex by performing the RCT with the patient's nose held closed. The RCT involves inhaling a concentration of 20% L-(+)-tartaric acid dissolved in normal, sterile saline (Nephron Pharmaceuticals, Orlando, FL) delivered via jet nebulizer.
- VC maximal forceful voluntary cough
- involuntary cough was elicited by stimulating the laryngeal cough reflex by performing the RCT with the patient's nose held closed
- An independent reviewer used the continuous pressure recording of each subject to determine peak pressures, measure duration of the cough events, count the number of pressure spikes, and derive area under the curve (AUC) numbers.
- Peak pressures were similar when comparing voluntary cough with the RCT ( Figures 7A and 7B). Duration of cough events, AUC, and number of spikes were all increased with RCT relative to voluntary cough. Neither of the 2 normal subjects leaked with either cough maneuver. Of the 4 subjects with mild stress urinary incontinence (diagnosed by I-QOL), 3 leaked with RCT and 2 leaked with VC. A possible carryover effect was identified when assessing subjects that were randomized to undergo RCT testing prior to VC. There appear to be a relative increase in AUC, peak pressure, duration, and in the number of spikes with VC testing when voluntary cough testing was performed after, rather then prior art to, the RCT ( Figures 7A and 7B). It is notable that both subjects that leaked with voluntary cough were randomized to have the RCT performed first.
- RCT provides considerable "stress" in subjects with stress urinary incontinence and appears to be a useful involuntary maneuver in eliciting leakage in subjects with this condition. No other involuntary maneuver has been studied in evaluating this condition. The data suggests that RCT may be more efficient in provoking leakage in subjects with stress urinary incontinence than voluntary cough.
- the present invention has been described above, in which description preferred embodiments of the invention are discussed. Unless otherwise defined, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described above.
Abstract
Techniques for detecting stress urinary incontinence use a pressure sensing catheter the electrical indications of which are applied to a processing unit for detecting pressure levels generated during involuntary coughs. The involuntary coughs are induced preferentially by using a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier. The area under the curve generated from pressure samples is calculated and used in conjunction with the detection of urine leakage to determine the existence of stress urinary incontinence.
Description
TECHNIQUES FOR EVALUATING URINARY STRESS INCONTINENCE
Cross Reference to Related Applications
This application incorporates by reference in its entirety and claims priority to U.S. Provisional Application Serial No. 60/727,740, filed October 18, 2005, entitled Method of Diagnosing Stress Incontinence by Involuntary Cough by inventor W. Robert Addington, Stuart Miller and Robert Stephens, and claims priority to and incorporates by reference U.S. Provisional Application Serial No. 60/752,351, filed December 21, 2005, entitled Foley Catheter Having Pressure Transducer by W. Robert Addington and Mary Briganti. This application is related to U.S. Patent Application Serial No. 10/783,442, filed February 20, 2004, entitled Apparatus For Evaluating A Patient's Laryngeal Cough Reflex And Associated Methods by W. Robert Addington, Stuart Miller and Robert Stephens, which is incorporated herein by reference in its entirety.
Background of the Invention Field of the Invention
This invention is directed to the field of medical devices and testing and, more particularly, to apparatus and techniques for evaluating urinary stress incontinence.
Description of the Prior Art
According to the American Academy of Family Physicians, urinary incontinence (UI) affects approximately twelve million persons in the United States alone. Although urinary incontinence can occur in both men and women, it is most common in women over the age of 50. There are many causes of UI, including age related atrophic changes in the genitourinary anatomy in women after menopause, enlargement of the prostate in men as well as generalized weakening of the pelvic floor muscles, medication side effects, immobility, infection of the urinary tract and various underlying medical comorbidities including diabetes and hypercalcemia.
There are four basic types of urinary incontinence; functional, overflow, urge and stress. Stress incontinence occurs when there is a sudden pressure on the lower abdominal
musculature, such as with a cough, sneeze, laugh or lifting. Stress incontinence is often secondary in part to weakening of the pelvic floor musculature, and is common after childbirth or abdominal surgery. It has been estimated that stress urinary incontinence occurs at least weekly in one third of adult women. (1) Additional reports indicate that more than 65% of female incontinence patients in the United States or 8.3 million women experience stress urinary incontinence. Of these women, approximately 85% or 7 million have incontinence primarily due to hypermobility of the bladder outlet, and approximately 15% or 1.3 million have incontinence primarily due to an intrinsic sphincter deficiency. Regardless of the etiology of UI, for the affected person it maybe a source of significant embarrassment and social isolation. As a result of this social stigma, many patients are reluctant to address this issue with their physician. Most primary care physicians "screen" for urinary incontinence by verbal or written questioning of the patient only. Additional basic evaluation may include a voluntary cough stress test, voiding diary, post void residual urinary volume, and urinalysis. (2)
A patient experiencing urinary incontinence must be properly diagnosed to identify the specific type of incontinence from which the patient suffers. The treatments may be different, depending on the type of incontinence. Therefore, proper diagnosis becomes important at least for that reason.
Stress incontinence may result primarily in older women due to loss of extrinsic support for the pelvic organs and for the neck of the bladder. The tissues of the pelvis and of the distal urethra contain estrogen and progesterone receptors. Following menopause- and decrease of the hormones, the tissues of the urethra may lose resiliency and become somewhat flaccid. Under those conditions, any increase in intra-abdominal pressure causes urine in the bladder to be pushed outwardly as resistance in the urethra is overcome, resulting in leakage of urine. This condition is known as stress incontinence and occurs in the absence of contractions by the detrusor muscle of the bladder. Stress incontinence may be responsive to treatment with exogenous estrogens, although this is not an effective treatment for all patients, particularly depending on age. Alternative treatments may include pelvic muscle exercises, α-adrenergic agents, such as
phenylpropanolamine, that act on the α-adrenergic receptors along the urethra and increase urethral tone.
The most common cause of urinary incontinence, however, is detrusor hyperreflexia, or hyperactivity of the detrusor- muscle. This type of incontinence is believed to result from lack of inhibition of the detrusor muscle due to a decreased detrusor reflex in the brain stem. Nevertheless, in most affected elderly there appears to be no underlying neurological defect. In this condition, treatment may include antispasmodic agents which tend to relax the wall of the bladder.
A typical test employed to distinguish these two types of urinary incontinence is one which increases intra-abdominal pressure so as to, in turn, put pressure on the bladder. The Valsalva maneuver is one such test. In this technique, the patient generates a muscular contraction of the chest, abdomen and diaphragm in a forced expiration against a closed glottis. This increases pressure within the thoracic cavity and also in the abdominal cavity. The Valsalva maneuver also refers to raising the pressure in the nasopharynx by a forced expiration with the mouth closed and the nostrils pinched, for example, to clear the patency of the Eustachian tubes. Other testing techniques involve having the patient jump up and down to jostle the bladder, or bend down so as to compress the abdomen. Yet another method involves having the patient generate one or more strong voluntary coughs.
It is known, however, that some patients are unable to perform these physical acts. For example, a patient may not be able to jump, or to bend, or to generate a strong voluntary cough. Additionally, there are some patients who will not be correctly diagnosed on the basis of the cough test, perhaps because their coughs are insufficiently strong. Accordingly, there is a need for alternative or supplementary tests that will aid in diagnosing urinary stress incontinence.
A rather complete discussion of methods of evaluating urinary incontinence is found in a February 2006 article by JL Martin et al. entitled "Systematic review and
evaluation of methods of assessing urinary incontinence (hereinafter referred to as Systematic review)."
Problems of the Prior Art
One of the problems associated with the prior art techniques is that some patient's are unable or are unwilling to perform the physical acts to the extent needed. For example, a patient may not be able to jump, or to bend, or to generate a strong voluntary cough. For some patient's they maybe able to perform these acts, but be unwilling to do so because an involuntary release of urine maybe embarrassing or contrary to what is considered proper in society.
Brief Summary of the Invention
Various aspects of the invention are directed toward apparatus and techniques for evaluating urinary stress incontinence. Particularly, the invention is directed toward evaluating urinary stress incontinence using a reflexive cough test (RCT), which triggers an involuntary cough on the part of the patient. Such an involuntary cough overcomes some of the problems of prior art techniques and produces a more reliable test for urinary stress incontinence.
Brief Description of the Drawings
The invention will be described more in detail with reference to the following drawings.
Figure 1 shows a flow chart of a technique for evaluating a patient for urinary stress incontinence in accordance with one aspect of the invention.
Figure 2 shows a flow chart of a technique for conducting a reflexive cough test (RCT).
Figure 3 shows a catheter that can be used for carrying out various aspects of the invention.
Figure 4 is an illustration of a hand held processing device that can be used to carry out the invention.
Figure 5 is a block diagram of an exemplary processing device that can be used to carry out aspects of the invention.
Figure 6 is a flow chart of software use to program a processing device in accordance with one aspect of the invention.
Figure 7A and 7B illustrate test results comparing voluntary cough and involuntary cough techniques for assessing stress urinary incontinence.
Detailed Description of the Invention
Figure 1 shows a flow chart of a technique for evaluating a patient for urinary stress incontinence in accordance with one aspect of the invention. As an initial step, pressure sensing catheter is inserted into a patient's empty bladder (100). The patient's bladder is then filled slowly with sterile water until 200ml have been delivered (110).
The patient is then asked to voluntarily cough (120) and the results of the voluntary cough are recorded (130) by recording the variations in pressure as a function of time and by recording whether or not the cough induced involuntary expulsion of urine. See item 130.
Then, a reflex cough test is performed (140) and the results are recorded in a manner substantially similar to step 130. Details of the reflex cough tests are discussed more in conjunction with Figure 2.
Figure 2 shows a flow chart of a technique for conducting a reflex cough test. With the test arrangement in place as described in conjunction with items 100 and 110 of Figure 1, instead of asking a patient to voluntarily cough, the patient is administered a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier (200). The variations in bladder pressure that occur during the involuntary coughs induced by step 200 are then recorded and plotted for display (210). The patient is checked for any urinary leakage that occurs during the involuntary coughs (220).
Figure 3 shows a catheter that can be used for carrying out various aspects of the invention. A catheter, 300, includes a pressure sensor 310 and conductive wires or paths which conduct the electrical output of the pressure sensor 310 to external circuitry. The wires or paths are hereinafter called pressure sensor leads 320. The catheter lumen can be utilized to fill or drain the patient's bladder as appropriate. Examples of a catheter usable in accordance with the invention may include a Foley catheter equipped with a pressure sensor.
Figure 4 is an illustration of a hand held processing device that can be used to carry out the invention. As shown on the device display screen, the variation in pressure that occurs as a function of time during a voluntary or involuntary cough is displayed.
Figure 5 is a block diagram of an exemplary processing device that can be utilized to carry out aspects of the invention. Figure 5 is a block diagram that illustrates a computer system 500 upon which an embodiment of the invention may be implemented. Computer system 500 includes a bus 502 or other communication mechanism for communicating information, and a processor 504 coupled with bus 502 for processing information. Computer system 500 also includes a main memory 506, such as a random access memory (RAM) or other dynamic storage device, coupled to bus 502 for storing information and instructions to be executed by processor 504. Main memory 506 also may be used for storing temporary variables or other intermediate information during execution of instructions to be executed by processor 504. Computer system 500 further includes a read only memory (ROM) 508 or other static storage device coupled to bus 502 for storing static information and instructions for processor 504. A storage device 510, such as a magnetic disk or optical disk, is provided and coupled to bus 502 for storing information and instructions.
Computer system 500 may be coupled via bus 502 to a display 512, such as a cathode ray tube (CRT), for displaying information to a computer user. An input device 514, including alphanumeric and other keys, is coupled to bus 502 for communicating information and command selections to processor 504. Another type of user input device
is cursor control 516, such as a mouse, a trackball, or cursor direction keys for communicating direction information and command selections to processor 104 and for controlling cursor movement on display 512. This input device typically has two degrees of freedom in two axes, a first axis (e.g., x) and a second axis (e.g., y), that allows the device to specify positions in a plane.
Computer system 500 operates in response to processor 504 executing one or more sequences of one or more instructions contained in main memory 506. Such instructions may be read into main memory 506 from another computer-readable medium, such as storage device 510. Execution of the sequences of instructions contained in main memory 506 causes processor 504 to perform the process steps described herein. In alternative embodiments, hard- wired circuitry may be used in place of or in combination with software instructions to implement the invention. Thus, embodiments of the invention are not limited to any specific combination of hardware circuitry and software.
The term "computer-readable medium" as used herein refers to any medium that participates in providing instructions to processor 504 for execution. Such a medium may take many forms, including but not limited to, non- volatile media, volatile media, and transmission media. Non- volatile media includes, for example, optical or magnetic disks, such as storage device 510. Volatile media includes dynamic memory, such as main memory 506. Transmission media includes coaxial cables, copper wire and fiber optics, including the wires that comprise bus 502. Transmission media can also take the form of acoustic or light waves, such as those generated during radio-wave and infra-red data communications.
Common forms of computer-readable media include, for example, a floppy disk, a flexible disk, hard disk, magnetic tape, or any other magnetic medium, a CD-ROM, any other optical medium, punchcards, papertape, any other physical medium with patterns of holes, a RAM, a PROM, and EPROM, a FLASH-EPROM, any other memory chip or
cartridge, a carrier wave as described hereinafter, or any other medium from which a computer can read.
Various forms of computer readable media may be involved in carrying one or more sequences of one or more instructions to processor 504 for execution. For example, the instructions may initially be carried on a magnetic disk of a remote computer. The remote computer can load the instructions into its dynamic memory and send the instructions over a telephone line using a modem. A modem local to computer system 500 can receive the data on the telephone line and use an infra-red transmitter to convert the data to an infra-red signal. An infra-red detector can receive the data carried in the infra-red signal and appropriate circuitry can place the data on bus 502. Bus 502 carries the data to main memory 506, from which processor 504 retrieves and executes the instructions. The instructions received by main memory 506 may optionally be stored on storage device 510 either before or after execution by processor 504.
Figure 6 is a flow chart of software used to program a processing device in accordance with one aspect of the invention. The processing device is programmed to repetitively sample pressure output from the sensor (600). Upon receipt of an initiation or start signal, the processor can start recording data from the pressure sensor (610). The start signal can be generated by utilizing either a rapid increase in pressure, by detecting a pressure threshold being exceeded, or by receiving a trigger signal initiated by a user. Such a signal was discussed in conjunction with U.S. Patent Application Serial No. 10/783,442, filed February 20, 2004, entitled Apparatus For Evaluating A Patient's Laryngeal Cough Reflex And Associated Methods, by W. Robert Addington, Stuart Miller and Robert Stephens, referred to above.
After receipt of the starts signal, the processing unit stores the samples and displays the plot of the pressure sample values (620).
Upon completion of the cough sequence, software is programmed to calculate the area under the curve of a plot of the sample values (630). The areas under the curve
(AUC) values are calculated by the numerical integration of intravesical pressure over time with either Simpson's 3/8-rule or Bode (or Boole's) rule. Both Simpson's 3/8-rule and Bode (or Boole's) rule are methods of numerical integration that yield more accurate results for AUC than the trapezoidal method.
Simpson's 3/8 rule
f(x)dx m -j {/o + /w + 3(/i + /4 + .-. + /«-2)
+ 3(/2 + h + - + /a-l) + Hk + ft + - + /n-3)}
= f < /<*) + f(β) +3 ]T /(Λ + tΛ)
I=I5-I3T3...
Bode's (Boole's) rule
Pf {x) dx = ^ h U f1 + 32 /2 + 12 /3 + 32 /4 + 7/5) - JL- ^7 /(6) g).
All AUC values were calculated using Bode's (Boole's) rule, except for that of Patient #1, which was calculated with Simpson's 3/8-rule. Bode's (Boole's) method was not very adept at handling as few data points (3).
The process may selectively display the calculated area under the curve to the user either with or separately from display of the plot of the sample values (640).
Optionally, one may output the raw and calculated data for use outside of the processing device (650). This can be done utilizing interface 518.
Figure 7A and 7B illustrate test results comparing voluntary cough and involuntary cough techniques for assessing stress urinary incontinence.
The testing that produced the results shown in Figure 7A and 7B are described as follows.
Objective
The objective of this study were to:
1. Evaluate the effectiveness of the reflex cough test (RCT) versus voluntary cough in confirming stress urinary incontinence in female subjects with a history of mild urinary incontinence as determined by the Incontinence Quality of Life Instrument (I-QOL); and
2. Correlate, if indicated, intravesicular pressure measurements with urinary leakage after RCT.
Materials and Methods
Voluntary and involuntary (RCT) cough provocation maneuvers were performed during urodynamic testing in 6 women. Four women had a history of mild stress urinary incontinence and two were normal controls. The order of the cough provocation procedures was randomized.
Prior to urodynamic assessment, subjects were instructed to empty the bladder (confirmed via ultrasound). Using sterile technique, calibrated bladder and rectal catheters were placed and continuous dual-channel pressure recording was performed and the subject's bladder was filled slowly with sterile water until 200 mL had been delivered.
Cough Leak Point Pressure (CLPP) was assessed with a bladder volume of 200 mL. Leakage was determined by visual inspection of the perineum by the Investigator during the coughs, and electronically marked on the print-out. If the subject did not leak with either cough maneuver in the semi-recumbent position, the standing position was used. Urodynamic testing was completed with filling to capacity to observe for detrusor instability.
After instruction, subjects performed a maximal forceful voluntary cough (VC) and an involuntary cough. The involuntary cough was elicited by stimulating the laryngeal cough reflex by performing the RCT with the patient's nose held closed. The RCT involves inhaling a concentration of 20% L-(+)-tartaric acid dissolved in normal, sterile saline (Nephron Pharmaceuticals, Orlando, FL) delivered via jet nebulizer.
An independent reviewer used the continuous pressure recording of each subject to determine peak pressures, measure duration of the cough events, count the number of pressure spikes, and derive area under the curve (AUC) numbers.
Results
Peak pressures were similar when comparing voluntary cough with the RCT (Figures 7A and 7B). Duration of cough events, AUC, and number of spikes were all increased with RCT relative to voluntary cough. Neither of the 2 normal subjects leaked with either cough maneuver. Of the 4 subjects with mild stress urinary incontinence (diagnosed by I-QOL), 3 leaked with RCT and 2 leaked with VC. A possible carryover effect was identified when assessing subjects that were randomized to undergo RCT testing prior to VC. There appear to be a relative increase in AUC, peak pressure, duration, and in the number of spikes with VC testing when voluntary cough testing was performed after, rather then prior art to, the RCT (Figures 7A and 7B). It is notable that both subjects that leaked with voluntary cough were randomized to have the RCT performed first.
Conclusion
RCT provides considerable "stress" in subjects with stress urinary incontinence and appears to be a useful involuntary maneuver in eliciting leakage in subjects with this condition. No other involuntary maneuver has been studied in evaluating this condition. The data suggests that RCT may be more efficient in provoking leakage in subjects with stress urinary incontinence than voluntary cough.
The present invention has been described above, in which description preferred embodiments of the invention are discussed. Unless otherwise defined, technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, suitable methods and materials are described above. In addition, the materials, methods and examples given are illustrative in nature only and not intended to be limiting. Accordingly, this invention may be embodied in many different forms and should not be construed as limited to the illustrated embodiments set forth herein. Rather, these illustrated embodiments are provided solely for exemplary purposes so that this disclosure will be thorough and complete, and will fully convey the scope of the invention to those skilled in the art. Other features and advantages of the invention will be apparent from the above detailed description, and from the claims.
Claims
1. A method for increasing intra-abdominal pressure, comprising the step of: a. inducing an involuntary maneuver in a patient that can produce stress incontinence in a clinical setting.
2. A method for detecting urinary stress incontinence, comprising the steps of: a. inserting a pressure sensing catheter into a patients empty bladder; b. filling the patient's bladder to a predetermined level; c. inducing one or more involuntary coughs in the patient; and d. recording pressure levels detected by the pressure sensing catheter during involuntary coughs; and e. determining urinary stress incontinence by identifying urine leakage accompanied by peak pressures above a given level.
3. The method of claim 2 in which the step of recording pressure levels comprises repeatedly sampling the pressure from the pressure sensing catheter.
4. The method of claim 2, in which the step of filling the patient's bladder is followed by having the patient produce a voluntary cough prior to or after the step of inducing one or more involuntary coughs.
5. The method of claim 4 in which the step of having the patient produce a voluntary cough occurs while recording pressure levels detected by the pressure sensing catheter during the voluntary cough.
6. The method of claim 2 in which the step of recording pressure levels detected by the pressure sensing catheter comprises the steps of: a. repeatedly sampling the pressure levels detected by the pressure sensing catheter; and b. recording the sampled pressure levels.
7. The method of claim 6 further comprising the step of plotting the sampled pressure levels and displaying the resulting plot to a user.
8. The method of claim 7, further comprising the step of calculating area under a curve resulting from the plot of the sampled pressure levels.
9. The method of claim 8, further comprising the step of displaying the value of the area under the curve.
10. The method of claim 8 comprising using Simpson's formula for calculating the area under the curve.
11. The method of claim 8 comprising using Bode's formula for calculating the area under the curve.
12. The method of claim 2 the step of inducing one or more involuntary coughs in the patient comprises administering a nebulized composition of L-tartrate in a pharmaceutically acceptable carrier.
13. The method of claim 2 in which the step of recording pressure levels detected by the pressure sensing catheter during involuntary coughs is initiated by one of; a. a rapid increase in pressure; b. a signal initiated by a user; or c. a signal initiated by activation of a nebulizer.
14. Apparatus for detecting urinary stress incontinence, comprising: a. a pressure sensing catheter; and b. a processor for receiving electrical signals from the pressure sensing catheter.
15. The apparatus of claim 14, in which the processor is configured to repetitively sample the electrical signals.
16. The apparatus of claim 15 in which the processor is configured to display a plot of samples of the electrical signals.
17. The apparatus of claim 16 in which the processor is configured to calculate area under a curve resulting from the plot of the samples of the electrical signals.
18. The method of claim 17 comprising using one of Simpson's formula and Bode's formula for calculating the area under the curve.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002625428A CA2625428A1 (en) | 2005-10-18 | 2006-10-17 | Techniques for evaluating urinary stress incontinence |
EP06849080.4A EP1937143B1 (en) | 2005-10-18 | 2006-10-17 | Apparatus for evaluating urinary stress incontinence |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72774005P | 2005-10-18 | 2005-10-18 | |
US60/727,740 | 2005-10-18 | ||
US75235105P | 2005-12-21 | 2005-12-21 | |
US60/752,351 | 2005-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007079271A2 true WO2007079271A2 (en) | 2007-07-12 |
WO2007079271A3 WO2007079271A3 (en) | 2007-12-13 |
Family
ID=38228898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/060032 WO2007079271A2 (en) | 2005-10-18 | 2006-10-17 | Techniques for evaluating urinary stress incontinence |
Country Status (5)
Country | Link |
---|---|
US (1) | US8690790B2 (en) |
EP (1) | EP1937143B1 (en) |
CA (1) | CA2625428A1 (en) |
DE (1) | DE202006021091U1 (en) |
WO (1) | WO2007079271A2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100137737A1 (en) * | 2005-10-18 | 2010-06-03 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test |
US20100137736A1 (en) * | 2005-12-09 | 2010-06-03 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
WO2010075274A1 (en) | 2008-12-22 | 2010-07-01 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test |
US20110040157A1 (en) * | 2005-10-18 | 2011-02-17 | PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: | Techniques for evaluating urinary stress incontinence and use of involuntary reflex cough as a medical diagnostic tool |
US20110040211A1 (en) * | 2005-10-18 | 2011-02-17 | Pneumoflex Systems, Llc | Oral-esophageal-gastric device to diagnose reflux and/or emesis |
US20110046653A1 (en) * | 2005-10-18 | 2011-02-24 | PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: Florida | Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis |
US20120190938A1 (en) * | 2011-01-20 | 2012-07-26 | Pneumoflex Systems, Llc | System and method of diagnosing acid reflux using involuntary reflex cough test |
US20120277547A1 (en) * | 2011-04-29 | 2012-11-01 | Pneumoflex Systems, Llc | System and method of testing the gastric valve and urethral sphincter |
US20130204313A1 (en) * | 2011-04-29 | 2013-08-08 | Pneumoflex Systems, Llc | System to diagnose the function of intrinsic sphincters |
CN103479353A (en) * | 2013-09-05 | 2014-01-01 | 常州大学 | Wireless warning system and wireless warning method for bedridden incontinent patients |
US20140235960A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device to block emesis and reflux and associated system and method |
US20140235957A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device with passive valve to block emesis and/or reflux and associated system and method |
US20140235958A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device with active valve to block emesis and reflux blockage device and associated system and method |
US20140288612A1 (en) * | 2012-04-26 | 2014-09-25 | Pneumoflex Systems, Llc | System to treat at least one of the urethral and anal sphincters |
US20150257695A1 (en) * | 2011-04-29 | 2015-09-17 | Pneumoflex Systems, Llc | Urinary catheter system for diagnosing a physiological abnormality such as stress urinary incontinence |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7455666B2 (en) | 2001-07-13 | 2008-11-25 | Board Of Regents, The University Of Texas System | Methods and apparatuses for navigating the subarachnoid space |
US9022027B2 (en) | 2004-02-20 | 2015-05-05 | Pneumoflex Systems, Llc | Nebulizer with intra-oral vibrating mesh |
FR2922095B1 (en) * | 2007-10-16 | 2010-09-03 | Cie Euro Etude Rech Paroscopie | DEVICE FOR INFLATION OF A SURGICAL IMPLANT |
US8360989B2 (en) * | 2009-03-13 | 2013-01-29 | Laborie Medical Technologies Canada Ulc | Valsalva lung pressure monitoring system and method |
US20110092955A1 (en) | 2009-10-07 | 2011-04-21 | Purdy Phillip D | Pressure-Sensing Medical Devices, Systems and Methods, and Methods of Forming Medical Devices |
US8671934B2 (en) | 2011-01-20 | 2014-03-18 | Pneumoflex Systems, Llc | Nebulizer that is activated by negative inspiratory pressure |
US9452270B2 (en) | 2011-01-20 | 2016-09-27 | Pneumoflex Systems, Llc | Nebulizer having replaceable nozzle assembly and suction line |
US20140202457A1 (en) | 2011-01-20 | 2014-07-24 | Pneumoflex Systems, Llc | Metered dose nebulizer |
US20120190999A1 (en) | 2011-01-20 | 2012-07-26 | Pneumoflex Systems, Llc | Pediatric nebulizer |
EP3777685A1 (en) * | 2011-11-28 | 2021-02-17 | Remendium Labs LLC | Treatment of urinary incontinence |
US20150112231A1 (en) | 2011-11-28 | 2015-04-23 | Remendium Labs Llc | Treatment of fecal incontinence |
EP3366212A1 (en) | 2012-01-30 | 2018-08-29 | Remendium Labs LLC | Treatment of pelvic organ prolapse |
EP2832290A4 (en) * | 2012-03-27 | 2015-11-18 | Suzhou Dawei Biopharma Ltd | System and method for monitoring bladder and abdominal pressures, and bladder function recovery system |
WO2014164175A2 (en) | 2013-03-13 | 2014-10-09 | Pneumoflex Systems, Llc | Metered dose nebulizer |
WO2014164243A1 (en) | 2013-03-13 | 2014-10-09 | Pneumoflex Systems, Llc | Nebulizer having replaceable nozzle assembly and suction line |
WO2014164241A2 (en) | 2013-03-13 | 2014-10-09 | Pneumoflex Systems, Llc | Metered dose atomizer |
WO2014159016A1 (en) | 2013-03-13 | 2014-10-02 | Pneumoflex Systems, Llc | Pulsed nebulizer |
US9277884B2 (en) * | 2013-03-14 | 2016-03-08 | Biofluid Technology, Inc. | Devices and methods for tissue immobilization and non-invasive lower urinary tract analysis |
AU2015203940A1 (en) | 2014-01-06 | 2016-07-21 | Remendium Labs Llc | System and method for Kegel training |
US11426626B2 (en) | 2016-07-29 | 2022-08-30 | Renovia Inc. | Devices, systems, and methods for training pelvic floor muscles |
USD888948S1 (en) | 2019-04-02 | 2020-06-30 | Renovia Inc. | Intravaginal device |
USD898911S1 (en) | 2019-04-03 | 2020-10-13 | Renovia Inc. | Intravaginal device assembly |
USD889649S1 (en) | 2019-04-05 | 2020-07-07 | Renovia Inc. | Intravaginal device |
USD896958S1 (en) | 2019-04-11 | 2020-09-22 | Renovia Inc. | Intravaginal device |
USD899593S1 (en) | 2019-04-12 | 2020-10-20 | Renovia Inc. | Intravaginal device |
USD897530S1 (en) | 2019-04-23 | 2020-09-29 | Renovia Inc. | Intravaginal device |
USD896959S1 (en) | 2019-04-23 | 2020-09-22 | Renovia Inc. | Intravaginal device |
USD922575S1 (en) | 2019-10-25 | 2021-06-15 | Renovia Inc. | Intravaginal device |
JP2021072926A (en) * | 2021-01-26 | 2021-05-13 | 株式会社塚田メディカル・リサーチ | Unitary bladder urine dynamic state measuring apparatus |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040015100A1 (en) | 2000-09-13 | 2004-01-22 | Schmidt Richard A. | Diagnosis of lower urinary tract dysregulation |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918893A (en) * | 1955-11-17 | 1959-12-29 | Clyde A Norton | Leakage indicator for liquid fuel systems |
US3286713A (en) * | 1965-02-23 | 1966-11-22 | Deknatel Inc | Surgical dressing |
US3373735A (en) * | 1965-10-21 | 1968-03-19 | John P. Gallagher | Medical-surgical tube |
US3426758A (en) * | 1966-10-10 | 1969-02-11 | American Hospital Supply Corp | Medical catheter with balloon leakage indicator |
US3895629A (en) * | 1974-10-15 | 1975-07-22 | Elizabeth M Snyder | Medical instrument retainer |
US4080970A (en) * | 1976-11-17 | 1978-03-28 | Miller Thomas J | Post-operative combination dressing and internal drain tube with external shield and tube connector |
US4214593A (en) * | 1978-09-18 | 1980-07-29 | Mallinckrodt, Inc. | Esophageal pressure monitoring device |
US4221215A (en) * | 1979-04-19 | 1980-09-09 | Isidore Mandelbaum | Anchoring and occluding surgical dressing |
US4613323A (en) * | 1984-11-19 | 1986-09-23 | University Of Kentucky Research Foundation | Multiple function intubation apparatus and method |
US4632119A (en) * | 1985-10-23 | 1986-12-30 | University Of Health Sciences/The Chicago Medical School | Ambulatory esophageal pH monitor |
GB8623020D0 (en) * | 1986-09-24 | 1986-10-29 | Young D E | Incontinence diagnostic & treatment device |
US4973314A (en) * | 1989-03-31 | 1990-11-27 | Susan Garrett | Combined dressing and retainer for surgically implanted catheter |
US4976261A (en) * | 1989-04-03 | 1990-12-11 | Advanced Pulmonary Technologies, Inc. | Endotracheal tube with inflatable cuffs |
US5146916A (en) * | 1990-01-05 | 1992-09-15 | Catalani Angelo S | Endotracheal tube incorporating a drug-irrigation device |
DK0608593T3 (en) | 1993-01-27 | 2006-10-30 | Medidenta Bv | Method and system for on-line measurement, storage, retrieval and analysis of urodynamic data |
US5433216A (en) * | 1993-06-14 | 1995-07-18 | Mountpelier Investments, S.A. | Intra-abdominal pressure measurement apparatus and method |
US5462539A (en) * | 1994-06-30 | 1995-10-31 | Herman; Ella H. | Hygiene (incontinence) pad for catheter users |
NL9401180A (en) | 1994-07-18 | 1996-03-01 | Draeger Med Electronics Bv | Catheter with multiple sensors at a distance from each other. |
US5678563A (en) * | 1995-11-16 | 1997-10-21 | Addington; W. Robert | Aspiration screening process for assessing need for modified barium swallow study |
US6561195B2 (en) * | 1995-11-16 | 2003-05-13 | Pneumoflex Systems L.L.C. | Laryngoscope nebulizer for application of chemostimulant to patient's larynx to stimulate involuntary cough reflex |
US6568397B1 (en) * | 1995-11-16 | 2003-05-27 | Pneumoflex Systems L.L.C. | Stimulation of nociceptor (irritant) and c-fibre receptors in patient's throat by nebulized application of chemostimulant and contrast material that allows fluoroscopy observation of larynx response for identifying patient's risk to dysphagia |
IL118154A0 (en) * | 1996-05-05 | 1996-09-12 | Influence Med Tech Ltd | An apparatus for the measurement of urethral angle change and leak point pressure |
US7317949B2 (en) * | 1996-11-08 | 2008-01-08 | Ams Research Corporation | Energy induced bulking and buttressing of tissues for incontinence |
US5862804A (en) * | 1997-07-08 | 1999-01-26 | Andco Tek, Inc. | Leak point wetness sensor for urological investigation |
US5904666A (en) * | 1997-08-18 | 1999-05-18 | L.Vad Technology, Inc. | Method and apparatus for measuring flow rate and controlling delivered volume of fluid through a valve aperture |
US5947943A (en) * | 1998-02-02 | 1999-09-07 | Lee; Frances Meiling | Diaper visual indicator |
US6679249B2 (en) * | 1998-04-21 | 2004-01-20 | Pneumoflex Systems, L.L.C. | Apparatus for treatment of chronic obstructive pulmonary disease and associated method |
US6004268A (en) | 1998-04-21 | 1999-12-21 | Addington; W. Robert | Aspiration screening process for assessing post surgery patient's risk for pneumonia |
US5980507A (en) * | 1998-04-30 | 1999-11-09 | Fassuliotis; Thomas M. | Catheter cot |
US6284942B1 (en) * | 1998-05-04 | 2001-09-04 | Long Island Jewish Medical Center | Confidence building incontinence pad |
EP1604653A1 (en) * | 1998-09-30 | 2005-12-14 | Takeda Pharmaceutical Company Limited | Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder |
US6461332B1 (en) * | 1998-10-19 | 2002-10-08 | Surx, Inc. | Urinary incontinence diagnostic system |
US6976950B2 (en) * | 2000-04-14 | 2005-12-20 | Solace Therapeutics, Inc. | Implantable valved pressure attenuation device |
EP1179329B1 (en) | 2000-07-21 | 2010-03-31 | The Procter & Gamble Company | Dark colored absorbent articles with loading indicator |
JP3942819B2 (en) * | 2000-11-17 | 2007-07-11 | ユニ・チャーム株式会社 | Absorbent pad suitable for use with tampon |
US7322359B2 (en) * | 2001-02-16 | 2008-01-29 | Srs Medical Systems, Inc. | Leak point wetness sensor for urological investigations |
KR20040015754A (en) * | 2001-06-29 | 2004-02-19 | 에디컨인코포레이티드 | A system and method for assessing urinary function |
EP1409050A2 (en) * | 2001-07-16 | 2004-04-21 | Pneumoflex Systems L.L.C. | Apparatus for self-induced cough-cardiopulmonary resuscitation |
JP3971150B2 (en) * | 2001-10-23 | 2007-09-05 | ユニ・チャーム株式会社 | Absorbent article and container for absorbent article |
DE10153416A1 (en) * | 2001-10-30 | 2003-05-22 | Berufsgenossenschaftlicher Ver | Device for examining disorders of bladder function |
US7402157B2 (en) * | 2001-12-19 | 2008-07-22 | The Procter & Gamble Company | Absorbent article having perception of depth |
GB0210073D0 (en) | 2002-05-02 | 2002-06-12 | Gaeltec Ltd | Improved apparatus and method for investigating the hollow viscera |
ATE355010T1 (en) * | 2002-10-30 | 2006-03-15 | Dpcom As | METHOD FOR ANALYZING SINGLE PULSE PRESSURE WAVES |
AU2004213030A1 (en) * | 2003-02-20 | 2004-09-02 | Pneumoflex Systems, Llc | Apparatus for evaluating a patient's laryngeal cough reflex and associated methods |
US7493158B2 (en) * | 2003-09-05 | 2009-02-17 | Sandhill Scientific, Inc. | Esophageal function display and playback system and method for displaying esophageal function |
US7089050B2 (en) * | 2003-09-15 | 2006-08-08 | Yitzhak Berger | Method and apparatus for measuring bladder electrical activity to diagnose bladder dysfunction |
WO2005052938A1 (en) * | 2003-11-28 | 2005-06-09 | Fujitsu Limited | Optical disc and recording/reproduction device |
US7332642B2 (en) * | 2004-04-19 | 2008-02-19 | The Procter & Gamble Company | Disposable absorbent articles having printed wetness indicators |
US7140370B2 (en) * | 2004-04-21 | 2006-11-28 | Chrickemil, L.L.C. | Endotracheal tube system and method of use |
US20050288603A1 (en) * | 2004-06-24 | 2005-12-29 | Goping Ing H F | Method for obtaining and displaying urethral pressure profiles |
US20070225576A1 (en) * | 2005-06-15 | 2007-09-27 | Alpine Biomed Corp. | Wireless ambulatory gastrointestinal monitoring system |
WO2007081626A2 (en) | 2005-12-09 | 2007-07-19 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool |
DE602006017366D1 (en) * | 2006-08-25 | 2010-11-18 | Pulsion Medical Sys Ag | Enteral feeding catheter and device for determining intra-abdominal pressure |
US7794425B2 (en) * | 2006-12-21 | 2010-09-14 | Kimberly-Clark Worldwide, Inc. | Gastro-esophageal reflux control system and pump |
JP5175863B2 (en) | 2007-01-29 | 2013-04-03 | ホリスター・インコーポレイテッド | Apparatus and method for collecting urine samples |
US20080208151A1 (en) * | 2007-02-23 | 2008-08-28 | Whetstone Management Llc | Marker system |
-
2006
- 2006-10-17 WO PCT/US2006/060032 patent/WO2007079271A2/en active Application Filing
- 2006-10-17 US US11/550,125 patent/US8690790B2/en active Active
- 2006-10-17 DE DE202006021091U patent/DE202006021091U1/en not_active Expired - Lifetime
- 2006-10-17 CA CA002625428A patent/CA2625428A1/en not_active Abandoned
- 2006-10-17 EP EP06849080.4A patent/EP1937143B1/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040015100A1 (en) | 2000-09-13 | 2004-01-22 | Schmidt Richard A. | Diagnosis of lower urinary tract dysregulation |
Non-Patent Citations (2)
Title |
---|
L. CORMIER ET AL., JOURNAL OF UROLOGY, vol. 167, pages 2083 - 2987 |
See also references of EP1937143A4 |
Cited By (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8597184B2 (en) | 2005-10-18 | 2013-12-03 | Pneumoflex Systems, Llc | Techniques for evaluating urinary stress incontinence and use of involuntary reflex cough as a medical diagnostic tool |
US9028406B2 (en) * | 2005-10-18 | 2015-05-12 | Pneumoflex Systems, Llc | Oral-esophageal-gastric device to diagnose reflux and/or emesis |
US9011328B2 (en) | 2005-10-18 | 2015-04-21 | Pneumoflex Systems, Llc | Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis |
US8845533B2 (en) * | 2005-10-18 | 2014-09-30 | Pneumoflex Systems, Llc | Techniques for evaluating urinary stress incontinence and use of involuntary reflex cough as a medical diagnostic tool |
US20110040157A1 (en) * | 2005-10-18 | 2011-02-17 | PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: | Techniques for evaluating urinary stress incontinence and use of involuntary reflex cough as a medical diagnostic tool |
US20110040211A1 (en) * | 2005-10-18 | 2011-02-17 | Pneumoflex Systems, Llc | Oral-esophageal-gastric device to diagnose reflux and/or emesis |
US20110046653A1 (en) * | 2005-10-18 | 2011-02-24 | PNEUMOFLEX SYSTEMS, LLC, State of Incorporation: Florida | Oral-esophageal-gastric device with esophageal cuff to reduce gastric reflux and/or emesis |
US8845534B2 (en) | 2005-10-18 | 2014-09-30 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (SUI) using involuntary reflex cough test |
US20140088375A1 (en) * | 2005-10-18 | 2014-03-27 | Pneumoflex Systems, Llc | Techniques for evaluating urinary stress incontinence and use of involuntary reflex cough as a medical diagnostic tool |
US20140088376A1 (en) * | 2005-10-18 | 2014-03-27 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test |
US20100137737A1 (en) * | 2005-10-18 | 2010-06-03 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test |
US8602987B2 (en) | 2005-10-18 | 2013-12-10 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (SUI) using involuntary reflex cough test |
US20140046145A1 (en) * | 2005-12-09 | 2014-02-13 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
US20100137736A1 (en) * | 2005-12-09 | 2010-06-03 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
US8597183B2 (en) | 2005-12-09 | 2013-12-03 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
US8840550B2 (en) | 2005-12-09 | 2014-09-23 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
WO2010075277A1 (en) | 2008-12-22 | 2010-07-01 | Pneumoflex Systems, Llc | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
CN102325494A (en) * | 2008-12-22 | 2012-01-18 | 纽莫弗莱克系统有限责任公司 | Involuntary contraction induced pressure as a medical diagnostic tool using involuntary reflex cough test |
WO2010075274A1 (en) | 2008-12-22 | 2010-07-01 | Pneumoflex Systems, Llc | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test |
US20120190938A1 (en) * | 2011-01-20 | 2012-07-26 | Pneumoflex Systems, Llc | System and method of diagnosing acid reflux using involuntary reflex cough test |
US20130204313A1 (en) * | 2011-04-29 | 2013-08-08 | Pneumoflex Systems, Llc | System to diagnose the function of intrinsic sphincters |
US20150257695A1 (en) * | 2011-04-29 | 2015-09-17 | Pneumoflex Systems, Llc | Urinary catheter system for diagnosing a physiological abnormality such as stress urinary incontinence |
US20120277547A1 (en) * | 2011-04-29 | 2012-11-01 | Pneumoflex Systems, Llc | System and method of testing the gastric valve and urethral sphincter |
US9005121B2 (en) * | 2011-04-29 | 2015-04-14 | Pneumoflex Systems, Llc | System and method of testing the gastric valve and urethral sphincter |
US9232917B2 (en) | 2011-04-29 | 2016-01-12 | Pneumoflex Systems, Llc | Urinary catheter system for diagnosing a physiological abnormality such as stress urinary incontinence |
US20130289363A1 (en) * | 2011-04-29 | 2013-10-31 | Pneumoflex Systems, Llc | Method for diagnosing the function of intrinsic sphincters |
US20140288612A1 (en) * | 2012-04-26 | 2014-09-25 | Pneumoflex Systems, Llc | System to treat at least one of the urethral and anal sphincters |
US9005124B2 (en) * | 2013-02-15 | 2015-04-14 | Pneumoflex Systems, Llc | Device to block emesis and reflux and associated system and method |
US9005122B2 (en) * | 2013-02-15 | 2015-04-14 | Pneumoflex Systems, Llc | Device with passive valve to block emesis and/or reflux and associated system and method |
US9005123B2 (en) * | 2013-02-15 | 2015-04-14 | Pneumoflex Systems, Llc | Device with active valve to block emesis and reflux blockage device and associated system and method |
US20140235958A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device with active valve to block emesis and reflux blockage device and associated system and method |
US20140235957A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device with passive valve to block emesis and/or reflux and associated system and method |
US20140235960A1 (en) * | 2013-02-15 | 2014-08-21 | Pneumoflex Systems, Llc | Device to block emesis and reflux and associated system and method |
CN103479353A (en) * | 2013-09-05 | 2014-01-01 | 常州大学 | Wireless warning system and wireless warning method for bedridden incontinent patients |
Also Published As
Publication number | Publication date |
---|---|
US20070255090A1 (en) | 2007-11-01 |
EP1937143A4 (en) | 2009-10-28 |
CA2625428A1 (en) | 2007-07-12 |
US8690790B2 (en) | 2014-04-08 |
WO2007079271A3 (en) | 2007-12-13 |
EP1937143A2 (en) | 2008-07-02 |
DE202006021091U1 (en) | 2012-11-12 |
EP1937143B1 (en) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1937143B1 (en) | Apparatus for evaluating urinary stress incontinence | |
US20210106787A1 (en) | Treatment of urinary incontinence | |
US8652066B2 (en) | Involuntary contraction induced pressure as a medical diagnostic tool | |
Stöhrer et al. | The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures | |
US20100137737A1 (en) | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test | |
Griffiths et al. | Dynamic testing | |
WO2010075274A1 (en) | Techniques for evaluating stress urinary incontinence (sui) using involuntary reflex cough test | |
CN113286545A (en) | Devices, systems, and methods for monitoring bladder function | |
KR20200104827A (en) | Systems and methods for diagnosing lower urinary tract dysfunction | |
Nguyen et al. | The effect of patient position on leak-point pressure measurements in women with genuine stress incontinence | |
Constantinou | Urethrometry: considerations of static, dynamic, and stability characteristics of the female urethra | |
Elia et al. | Periurethral collagen implant: ultrasound assessment and prediction of outcome | |
KR100421475B1 (en) | Urinary incontinence diagnostic system | |
MX2008005053A (en) | Techniques for evaluating urinary stress incontinence | |
Bristow et al. | Assessment and investigations for urinary incontinence | |
Bergman | Office work-up of lower urinary tract dysfunctions and indications for referral for urodynamic testing | |
Aathi et al. | Understanding of urodynamics testing | |
Choe | Pubovaginal sling surgery without using abdominal leak point pressure: an outcomes analysis | |
Agarwal et al. | Minimally Invasive Therapy for Urinary Incontinence and Pelvic Organ Prolapse (Current Clinical Urology) 2014th | |
Wyndaele | Urodynamic Investigations: Do They Make a Difference in the Outcome? | |
Agarwal et al. | Urodynamics: Indications, Technique, and Fluoroscopy | |
Hameed et al. | Urodynamic findings in female patients reporting with lower urinary tract symptoms | |
Corcos | Neurogenic Bladder Dysfunction | |
Di Lena et al. | Functional Assessment of Anorectal Function | |
Chapple et al. | Diagnostic Evaluation of Urinary Incontinence |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REEP | Request for entry into the european phase |
Ref document number: 2006849080 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006849080 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2625428 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Country of ref document: MX Ref document number: MX/a/2008/005053 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |